| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.02▼ | 2.91▲ | 2.89▲ | 2.80▲ | 3.56▼ |
| MA10 | 2.96▲ | 2.82▲ | 2.70▲ | 3.06▼ | 3.98▼ |
| MA20 | 2.90▲ | 2.78▲ | 2.85▲ | 3.48▼ | 4.16▼ |
| MA50 | 2.84▲ | 3.30▼ | 3.50▼ | 3.87▼ | 8.61▼ |
| MA100 | 3.40▼ | 3.80▼ | 3.80▼ | 4.15▼ | 23.19▼ |
| MA200 | 3.76▼ | 3.98▼ | 4.06▼ | 7.31▼ | 51.98▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.020▲ | 0.079▲ | 0.075▲ | -0.081▼ | 0.276▲ |
| RSI | 55.884▲ | 52.337▲ | 48.952▼ | 39.225▼ | 36.356▼ |
| STOCH | 78.035 | 44.920 | 37.184 | 16.242▼ | 20.353 |
| WILL %R | -30.000 | -53.030 | -53.030 | -56.790 | -86.139▼ |
| CCI | 79.418 | 106.098▲ | 106.242▲ | -52.933 | -149.226▼ |
|
Friday, November 14, 2025 01:44 PM
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by ...
|
|
Monday, November 10, 2025 04:50 AM
HCW Biologics (HCWB) announced the latest updated data for its tetra-valent, second-generation pembrolizumab-based Immune Checkpoint Inhibitor, ...
|
|
Monday, November 10, 2025 04:12 AM
HCW11-040 expands and activates human peripheral blood lymphocytes (PBMCs) and memory T cells significantly better than pembrolizumab alone. HCW11-040 exhibits significantly better anti-tumor activity ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 2.46 | 3.78 | 2.30 | 3.00 | 1,738,491 |
| 13/11/25 | 2.59 | 2.5955 | 2.34 | 2.49 | 42,356 |
| 12/11/25 | 2.80 | 2.8995 | 2.58 | 2.60 | 64,250 |
| 11/11/25 | 3.07 | 3.07 | 2.75 | 2.83 | 27,148 |
| 10/11/25 | 3.12 | 3.24 | 3.05 | 3.06 | 11,019 |
| 07/11/25 | 3.34 | 3.5929 | 2.87 | 3.02 | 43,680 |
| 06/11/25 | 3.35 | 3.40 | 3.2552 | 3.32 | 12,862 |
| 05/11/25 | 3.40 | 3.40 | 3.1401 | 3.31 | 22,209 |
| 04/11/25 | 3.60 | 3.802 | 3.23 | 3.40 | 65,527 |
| 03/11/25 | 3.82 | 3.82 | 3.58 | 3.60 | 14,781 |
|
|
||||
|
|
||||
|
|